Prestige Consumer Healthcare Inc. (FRA:PBV)

Market Cap	2.79B -22.6%
Revenue (ttm)	939.94M -1.3%
Net Income	158.84M -12.8%
EPS	3.23 -11.0%
Shares Out	n/a
PE Ratio	17.59
Forward PE	14.43
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	1
Open	58.00
Previous Close	55.50
Day's Range	57.50 - 58.00
52-Week Range	49.20 - 83.00
Beta	n/a
RSI	64.09
Earnings Date	Feb 5, 2026

About FRA:PBV

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers analgesic powders under the BC and Goody's brand; various diaper rash treatments and skin protectants for babies under the Boudreaux's Butt Paste brand name; sprays and lozenges to relieve sore throats and mo...

• Industry: Pharmaceutical Preparations
• Founded: 1996
• Employees: 600
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: PBV

Financial Performance

In fiscal year 2025, FRA:PBV's revenue was $1.14 billion, an increase of 1.10% compared to the previous year's $1.13 billion. Earnings were $214.61 million, an increase of 2.52%.

Financial numbers in USD